Wednesday, Sept. 27, 2023   Building a Better Malaria Vaccine--NIAID Researchers Design a Paradigm-Busting Candidate A new experimental malaria vaccine designed by NIAID researchers is based on structural features and interaction between two key malaria parasite proteins. In animal studies, the single-protein vaccine provided better protection against multiple strains of parasite than other vaccine candidates and would be easier to manufacture in large quantities. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107